sppunk said: "an Into The Woods type cast with stars coming and going."
The issue with your statement is that INTO THE WOODS has no stars (in the box office sense) now that Sara Bareilles is gone. It has solid theatre actors and beloved people in THIS community, but their name value does not transcend theatre diehards. ITW is also much more beloved than Mousetrap.
This being a play with, I assume, a somewhat modest capitalization, if they can get a bona fide star (or two or three) for the original cast who commit to 3-5 months, it could recoup in 16 weeks with the original cast. But the play itself will have no significant name value; virtually no plays have enough name value to do $800K+ a week for a sustained period of time, with incredibly rare exceptions (see: convo about Leopoldstadt, an outlyer). In America this will have to be a vehicle for stars.
I wish that wasn't the case, but the industry has rarely indicated otherwise. If a revival of an older play by a famous writer meant ticket sales, we'd see a lot better numbers for non-star revivals by Noel Coward, Tennessee Williams, Arthur Miller, Eugene O'Neill, Neil Simon, etc.
Updated On: 11/25/22 at 03:34 PM